What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
History
- Referred to health
- Referred to health
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S279
Title of bill
An act to amend the public health law and the education law, in relation to required labeling on prescription drugs
Purpose
To require the packaging on prescribed drugs to include a label that lists the country of origin of the prescribed drug to inform consumers.
Summary of provisions
Section one amends the public health law by adding a new article 33-B which requires the packaging of a prescribed drug to include a label that lists the country of origin of the drug.
Section two amends subdivision 2 of section 6811-a of the education law by adding paragraph (c) to include country of origin on the list of required markings on the packaging of a prescription drug.
Section three provides the effective date.
Justification
Pharmaceutical ingredients and finished drugs are produced worldwide and imported into the United States. According to the U.S. Department of Commerce, more than $42 billion in drugs and drug ingredients were imported into the U.S. from foreign nations in 2006. India and China are rapidly becoming some of the largest suppliers of pharmaceutical ingredients and finished drugs in the U.S. In the past five years, Chinese pharmaceutical imports have more than doubled. According to the u.s. Department of Commerce, in 2006, China exported approximately $675 million in pharmaceuticals to the United States and India sold finished drugs and ingredients worth more than $800 million in the United States. With recent concerns over toxins found in toys, toiletries and drugs produced in China and other countries, New York consumers should be made aware of where their prescription drugs are made. Consumers are informed of where their clothing, toys and household goods are made through a country of origin label, but currently have no way of knowing where their prescription drugs come from. This bill would allow New Yorkers to be informed of where their prescribed drugs are made just as they are informed of where other goods are made.
Legislative history
S.6813 of 2007-2008; Referred to Senate Health Committee S.3213 of 2009-2010; Referred to Senate Health Committee
Fiscal implications
None.
Effective date
This act shall take effect on the one hundred eightieth day after it shall have become law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.